Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Factors Associated With Psychiatric Symptoms in Methamphetamine-Induced Psychotic Disorder: One-Year Longitudinal Study

NCT07459257 is registered in ClinicalTrials.gov with Elazığ Mental Health and Diseases Hospital as lead sponsor.

NCT NCT07459257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07459257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Factors Associated With Psychiatric Symptoms in Methamphetamine-Induced Psychotic Disorder: One-Year Longitudinal Study
Lead sponsor
Elazığ Mental Health and Diseases Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2025
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine induced psychosis